1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

Background: Venous thromboembolism (VTE) is a common source of perioperative
morbidity and mortality. Objective: These evidence-based guidelines from the American …

Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …

Background VTE is a serious, but decreasing complication following major orthopedic
surgery. This guideline focuses on optimal prophylaxis to reduce postoperative pulmonary …

BACKGROUND & AIMS: A new generation of oral anticoagulants (nOAC), which includes
thrombin and factor Xa inhibitors, has been shown to be effective, but little is known about …

For most patients, direct oral anticoagulants (DOACs) are preferred over vitamin K
antagonists for stroke prevention in atrial fibrillation and for venous thromboembolism …

Background The original RE-LY (Randomized Evaluation of Long-term Anticoagulant
Therapy) trial suggested a small increased risk of myocardial infarction (MI) with the use of …

Context Symptomatic venous thromboembolism (VTE) after total or partial knee arthroplasty
(TPKA) and after total or partial hip arthroplasty (TPHA) are proposed patient safety …

For the past 60 years, oral vitamin K antagonists (eg, warfarin, acenocoumarol,
phenprocoumon, fluindione) have been widely prescribed. 5 However, their impact in …